Brief: Shandong Weigao Group Medical Polymer Sees Decrease In FY Revenue In Range Of 2% To 5%
30/01/2024 15:21
Jan 30 (Reuters) - Shandong Weigao Group Medical Polymer
Co Ltd 1066.HK :
* SEES DECREASE IN FY REVENUE IN RANGE OF 2% TO 5%
* SEES DECREASE IN FY NET PROFIT ATTRIBUTABLE IN RANGE OF
25% TO
30%
* EXPECTED RESULT DUE TO PRICE FALL PER PRODUCT SOLD OF
MEDICAL
DEVICES, AMONG OTHERS
Source text for Eikon: ID:n11053812-1
Further company coverage: 1066.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shandong Weigao Medical Polymer
See all newsChina's Weigao H1 profit falls 23% as price drops, competition hit margins
Brief: Shandong Weigao Group Medical Polymer H1 Net Income Attributable RMB 890.4 Mln
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 11.4 Million H Shares From 15 May 2026 To June 5
Brief: Shandong Weigao Group Medical Polymer Says Weigao Holding Purchases 3.6 Million H Shares
Brief: Shandong Weigao Group Medical Polymer Says Unit To Establish Fund Of KRW52.965 Billion